ZEISS OCT Angiography eNewsletter Series

  • VOLUME 1
  • VOLUME 2
  • VOLUME 3


What is OCT-A, and how does it differ from FA?

OCT-A stands for optical coherence tomography-angiography, which is a promising technology still under investigation. Currently, fluorescein angiography (FA) is the standard of care for evaluating numerous optical diseases, but it requires the injection of a dye to image the retinal vasculature. OCT-A...


Clinical Use of the New CIRRUS HD-OCT

My team and I have been using the CIRRUS prototype on an almost daily basis for the past few months to study eyes that we suspect of having macular or retinal pathology. High-definition OCT angiography (OCT-A) enables us to conduct an exploratory examination of what we think may be abnormal pathology...


AngioPlex May Help Detect Asymptomatic Choroidal Neovascularization in Dry AMD

I have maintained a research relationship with ZEISS for well over 10 years, and thus I have been involved in the development of the spectral-domain CIRRUS HD-OCT (ZEISS) system, as well as the new angiography platform known as AngioPlex OCT-angiography (OCT-A). AngioPlex OCT-A represents the beginning...


Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Scott Krzywonos

Janet Burk

About Retina Today

Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.